Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RFL |
---|---|---|
09:32 ET | 1492 | 1.47 |
10:03 ET | 139 | 1.51 |
10:42 ET | 500 | 1.475 |
10:53 ET | 500 | 1.46 |
10:57 ET | 132 | 1.46 |
11:13 ET | 200 | 1.48 |
11:31 ET | 200 | 1.4793 |
11:56 ET | 100 | 1.47 |
12:16 ET | 108 | 1.47 |
12:50 ET | 682 | 1.46 |
01:06 ET | 100 | 1.45 |
01:21 ET | 4935 | 1.45 |
01:32 ET | 209 | 1.45 |
01:37 ET | 500 | 1.454 |
02:49 ET | 100 | 1.43 |
03:03 ET | 200 | 1.4432 |
03:30 ET | 1298 | 1.44 |
03:32 ET | 800 | 1.43 |
03:38 ET | 1517 | 1.47 |
03:56 ET | 2364 | 1.42 |
03:59 ET | 0 | 1.43 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Rafael Holdings Inc | 35.2M | 16.4x | --- |
Presidential Realty Corp | 14.2K | 0.0x | --- |
Palmetto Real Estate Trust | 13.3M | 27.6x | +3.53% |
Power REIT | 2.4M | -0.1x | --- |
Medalist Diversified Reit Inc | 13.2M | -6.5x | --- |
Pillarstone Capital REIT | 9.9K | 0.0x | --- |
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $35.2M |
---|---|
Revenue (TTM) | $275.0K |
Shares Outstanding | 24.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.04 |
EPS | $0.09 |
Book Value | $4.13 |
P/E Ratio | 16.4x |
Price/Sales (TTM) | 127.8 |
Price/Cash Flow (TTM) | 13.4x |
Operating Margin | -4,729.82% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.